Subcutaneous Nivolumab as Effective as IV for Renal Cell Car

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in pati

Related Keywords

San Francisco , California , United States , New York , American , Saby George , Roswell Park , Roswell Park Care Network , National Cancer , Roswell Park Comprehensive Cancer Center , Bristol Myers Squibb , American Society Of Clinical Oncology , Clinical Oncology , Genitourinary Cancers Symposium , Network Clinical Trials , Has Spread , Moscone West , New York State , National Cancer Institute Designated , Upstate New , Newswise , Cc Renal Cell Carcinoma Nivolumab Ccrcc Asco Genitourinary Cancers Symposium Gu , All Journal News , Clinical Trials , Healthcare , Kidney Disease , Mbargoed Feed Hidden , Cancer Center Featured Story 2 , Grant Funded News ,